7-BROMO-4-CHLOROIMIDAZO[2,1-F][1,2,4]TRIAZINE, 95.0%, 100mg

1-(Trimethylsilyl)-1-pentyne>98.0%(GC)5g

ETHYL 4-((3-CHLORO-4-METHOXYBENZYL)AMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE, 95.0%, 100g

(3,5-Dimethyl-pyrazol-1-yl)-acetic acid ethyl ester, 5g

(4R,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-5,6,10,12,12a-pentahydroxy-6-methyl-1,3,11-trioxo-1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-carboxamide, 98%, 5mg

Boc-�-iodo-Ala-OMe, 95%, 100g

m-Xileno, mínimo 98,5 %, para síntesis, 2,5 l, envase de vidrio

Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate, 95.0%, 10g

N-((2S)-2-Amino-2-phenylethyl)-N,N-dimethylamine, 95.0%, 100mg

ETHYL N-(METHYLSULFONYL)GLYCINATE, 95%, 5g

Methyl 2-amino-3,4-difluorobenzoate, 99.0%, 25g

ethyl 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylate, 95.0%, 1g

SCIADOPITYSIN, 95%, 25mg